Branded Legacy Inc. Unveils Exciting Q4 2023 Milestones and Forges Ahead with Key Partnerships
- Established partnership with research facility for contract extraction and refinement services, expecting substantial revenues in Q4 2023
- Engaged in discussions with US retail brand and B2C distributor for collaborative product marketing and partnership opportunities
- In talks with FDA-approved laboratory for development and production of topicals
- None.
Accelerating Growth through Acquisition and Collaborations
Melbourne, FL -- September 28, 2023 -- InvestorsHub NewsWire -- Branded Legacy, Inc (OTC.PK: BLEG), a pioneering name in the biotech industry, is thrilled to share a quarterly summary of significant developments and partnerships, setting the stage for remarkable growth and innovation.
Elevating Research Capabilities
Branded Legacy has established a strategic partnership with a state-of-the-art research facility based in Williston/Alachua, Florida. This facility, previously visited in August of 2023, is dedicated to contract extraction and refinement services, positioning the company for substantial revenues in the fourth quarter of 2023. This strategic move enhances Branded Legacy's capacity to meet the growing demand for its services and products.
Exploring Retail and B2C Opportunities
Branded Legacy is actively engaged in open discussions with an emerging US retail brand and a leading business-to-consumer (B2C) distributor. These discussions center around collaborative product marketing and partnership opportunities. These potential partnerships are poised to amplify the reach of Branded Legacy's innovative solutions to a wider audience of consumers.
Advancements in Topical Product Line
In line with its commitment to quality and innovation, Branded Legacy is in discussions with a reputable Florida-based laboratory. This laboratory boasts an established FDA-approved product line, making it an ideal partner for the development and production of topicals. This collaboration aims to bring cutting-edge topical products to the market, meeting the evolving needs of consumers seeking wellness solutions.
David Oswald, CEO of Branded Legacy, stated, "These milestones and partnerships mark a significant step forward in our mission to provide high-quality biotechnological solutions to consumers. Our commitment to excellence and innovation drives our efforts to expand our capabilities and bring our products to a broader audience."
As the biotech industry continues to evolve, Branded Legacy remains at the forefront, dedicated to shaping the future of wellness and healthcare solutions.
For more information about Branded Legacy Inc. and its wide range of products, please visit www.brandedlegacy.com.
About Branded Legacy Inc.:
Branded Legacy Inc. is a forward-thinking biotechnology company dedicated to driving innovation in plant-derived medicines and biotechnological breakthroughs. The company's strategic partnerships and milestone achievements highlight its commitment to transforming patient care and contributing to the advancement of healthcare solutions.
Media Contact
Joe Holladay
Branded Legacy
Phone: 321-345-3565
Email: info@brandedlegacy.com Website: https://brandedlegacy.com/
Safe Harbor Statement on Forward-Looking Language:
This release includes forward-looking statements, which are based on certain assumptions and reflect management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. Dilution, if any, would be for the purposes of management taking stock in lieu of cash salary. The company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Additionally, this press release that is not statements of historical fact may be considered to be forward-looking statements. Written words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the near future.
View the original version - https://ih.advfn.com/stock-market/USOTC/BLEG/stock-news/92149136/branded-legacy-inc-unveils-exciting-q4-2023-miles
